XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/uncategorized/newsactelion-macitentan-drug-found-to-treat-pulmonary-arterial-hypertension/20%Daily2012-04-30 17:30
https://www.clinicaltrialsarena.com/uncategorized/newszalicus-concludes-patient-enrolment-in-rheumatoid-arthritis-trial/20%Daily2012-04-30 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsvyvanse-drug-meets-phase-2-study-endpoints-shire-reports/20%Daily2012-04-29 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgammagard-liquid-10-meets-primary-efficacy-endpoints-in-phase-iii-study/20%Daily2012-04-29 17:30
https://www.clinicaltrialsarena.com/uncategorized/newslevomilnacipran-drug-reports-positive-data-in-phase-iii-study/20%Daily2012-04-26 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnovartis-afinitor-drug-wins-fda-approval/20%Daily2012-04-26 17:30
https://www.clinicaltrialsarena.com/uncategorized/newseu-clears-novartis-signifor-drug-for-cushings-disease/20%Daily2012-04-25 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsrepligen-rg3039-drug-found-to-treat-neuromuscular-disorder/20%Daily2012-04-25 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssummit-wins-mhra-approval-to-begin-smt-c1100-phase-i-study/20%Daily2012-04-24 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsbiogen-idec-multiple-sclerosis-drug-reports-positive-phase-3-data/20%Daily2012-04-24 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsach-1625-combination-therapy-shows-complete-evr-against-hepatitis-c/20%Daily2012-04-23 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspolymedix-pmx-30063-shows-efficacy-against-staphylococcal-infections/20%Daily2012-04-23 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsinterferon-free-combination-regimen-shows-positive-hcv-data-abbott-reports/20%Daily2012-04-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsalnylam-aln-pcs-found-to-lower-ldl-cholesterol-phase-i-study/20%Daily2012-04-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssanofi-mjff-form-alliance-to-evaluate-parkinsons-drug/20%Daily2012-04-19 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmerck-reports-phase-iii-study-data-of-victrelis-combination-therapy/20%Daily2012-04-19 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscubist-entereg-drug-meets-phase-4-study-endpoints/20%Daily2012-04-18 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsjanssen-announces-incivo-data-from-phase-3-studies/20%Daily2012-04-18 17:30
https://www.clinicaltrialsarena.com/marketdata/featuredrug-pharmaceutical-sme-big-pharma-innovation/20%Daily2012-04-18 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmorphotek-begins-phase-ii-cancer-drug-study/20%Daily2012-04-17 17:30
https://www.clinicaltrialsarena.com/uncategorized/newslevodopa-carbidopa-intestinal-gel-shows-efficacy-against-parkinsons-abbott-reports/20%Daily2012-04-17 17:30
https://www.clinicaltrialsarena.com/marketdata/featurepharma-technology-focus-issue-12/20%Daily2012-04-17 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsbiodel-reports-positive-phase-i-rhi-trial-data/20%Daily2012-04-16 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsprosavin-meets-endpoints-in-parkinsons-study/20%Daily2012-04-16 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsalchemia-updates-on-phase-iii-cancer-drug-study/20%Daily2012-04-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsqgc-commences-phase-i-study-of-blood-pressure-monitoring-drug/20%Daily2012-04-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/newslonza-agennix-enter-into-talactoferrin-drug-development-deal/20%Daily2012-04-12 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsopko-health-begins-phase-3-trials-of-rolapitant-drug/20%Daily2012-04-12 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsqrxpharma-concludes-moxduo-cr-phase-1-studies-on-chronic-pain/20%Daily2012-04-11 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsuk-to-soon-open-applications-for-biomedical-catalyst-fund/20%Daily2012-04-11 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsurmc-temple-university-invest-in-drug-discovery-programme/20%Daily2012-04-10 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsfda-approves-marshall-edwards-cancer-drug-ind-application/20%Daily2012-04-10 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspresage-biosciences-signs-cancer-research-deal-with-millennium/20%Daily2012-04-09 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssyndax-begins-phase-12-study-of-entinostat-combination-therapy/20%Daily2012-04-09 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsucb-amgen-begin-phase-3-study-of-osteoporosis-drug/20%Daily2012-04-04 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsbind-announces-positive-preclinical-data-of-cancer-drug/20%Daily2012-04-04 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsqva149-phase-iii-studies-meet-primary-endpoints-novartis-reports/20%Daily2012-04-03 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgsk-reports-albiglutide-data-from-phase-lll-studies/20%Daily2012-04-03 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsshire-reports-phase-3-results-of-ulcerative-colitis-drug/20%Daily2012-04-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnektar-doses-first-patients-with-nktr-192-drug-in-phase-1-study/20%Daily2012-04-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgenentech-t-dm1-drug-found-to-extend-survival-time-in-cancer-patients/20%Daily2012-04-01 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsimmunogen-begins-phase-ii-study-of-cancer-drug/20%Daily2012-04-01 17:30